Literature DB >> 11848108

Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa.

F Bischof1, D Basu, J M Pettifor.   

Abstract

A high incidence of long-bone fractures has been observed in children and young adults with quadriplegic cerebral palsy in residential care. This study aimed to determine factors that contribute to these fractures and to institute preventive treatment. Twenty individuals (12 males, eight females) of a cohort of 88 residents with spastic quadriplegia in residential care in Gauteng, South Africa who had sustained fractures were compared with a random sample of age-matched control participants (10 males, 10 females) from the same facility. Participants ranged in age from 6 to 29 years (median 17.5 years). The majority of fractures were in the upper extremities. There was radiological and biochemical evidence of rickets and osteomalacia in both groups. However, the severity of the disease was more pronounced in the group with fractures. There was a significant relation (p=0.002) between the number of fractures and the use of anticonvulsant therapy (ACT). Three months of vitamin D administration (calciferol 5000 iu/day) resulted in a marked clinical improvement. There were no fractures during this period in either group. In addition, the mean serum calcium (Ca) and phosphate (Pi) levels increased (Ca from 2.17 to 2.35 mmol/L and Pi from 1.13 to 1.66 mmol/L) and mean total alkaline phosphatase level decreased (from 1123 to 423 U/L). We concluded that vitamin D deficiency was the major factor contributing to the occurrence of fractures in this population. Unless sunlight exposure can be guaranteed, vitamin D supplementation should be considered for children and adults in residential care, especially if they are on ACT, even in areas with year-round sunshine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848108     DOI: 10.1017/s0012162201001773

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

1.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

2.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  The functional muscle-bone unit in children with cerebral palsy.

Authors:  I Duran; F Schütz; S Hamacher; O Semler; C Stark; J Schulze; J Rittweger; E Schoenau
Journal:  Osteoporos Int       Date:  2017-04-01       Impact factor: 4.507

4.  Nutrition in neurologically impaired children.

Authors: 
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

5.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2009-08-19       Impact factor: 2.253

6.  Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy.

Authors:  A-K Finbråten; U Syversen; J Skranes; G L Andersen; R D Stevenson; T Vik
Journal:  Osteoporos Int       Date:  2014-08-14       Impact factor: 4.507

7.  Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities.

Authors:  Kathleen C Watson; Martha J Lentz; Kevin C Cain
Journal:  Womens Health Issues       Date:  2006 Nov-Dec

8.  Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents.

Authors:  Maria Luisa Bianchi; Sanford Baim; Nick J Bishop; Catherine M Gordon; Didier B Hans; Craig B Langman; Mary B Leonard; Heidi J Kalkwarf
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

Review 9.  Fractures in children with cerebral palsy.

Authors:  M Zulf Mughal
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 10.  Bone density in cerebral palsy.

Authors:  Christine Murray Houlihan; Richard D Stevenson
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.